quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·31d
PRRelease
Sanara MedTech Inc. logo

Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance

SMTI· Sanara MedTech Inc.
Health Care
Original source

Companies

  • SMTI
    Sanara MedTech Inc.
    Health Care

Recent analyst ratings

  • Apr 15UpdateLake Street$32.00
  • Mar 26UpdateH.C. Wainwright$51.00
  • Dec 23UpdateH.C. Wainwright$50.00
  • May 20UpdateCantor Fitzgerald$40.00
  • Jun 30UpdateCantor Fitzgerald$45.00

Related

  • SEC6d
    SEC Form DEFA14A filed by Sanara MedTech Inc.
  • SEC6d
    SEC Form DEFA14A filed by Sanara MedTech Inc.
  • SEC6d
    SEC Form DEF 14A filed by Sanara MedTech Inc.
  • INSIDER7d
    SEC Form 4 filed by Waldrop Jacob A.
  • ANALYST8d
    Lake Street initiated coverage on Sanara MedTech with a new price target
  • PR9d
    Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
  • SEC30d
    SEC Form 10-K filed by Sanara MedTech Inc.
  • SEC31d
    Sanara MedTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022